Additional File 10: Table S7. of Bile Acid is a Significant Host Factor Shaping the Gut Microbiome of Diet-Induced Obese Mice

Xuezhe Zheng,Fengjie Huang,Aihua Zhao,Sha Li,Yunjing Zhang,Guoxiang Xie,Tianlu Chen,Chun Qu,Cynthia Rajani,Bing Dong,Defa Li,Wei Jia

DOI: https://doi.org/10.6084/m9.figshare.5705335

2017-01-01

Abstract:Correlation of bile acids and microbiota in control and HFD groups. (XLSX 21 kb)

What problem does this paper attempt to address?

Additional File 12: Table S8. of Bile Acid is a Significant Host Factor Shaping the Gut Microbiome of Diet-Induced Obese Mice

Xuezhe Zheng,Fengjie Huang,Aihua Zhao,Sha Li,Yunjing Zhang,Guoxiang Xie,Tianlu Chen,Chun Qu,Cynthia Rajani,Bing Dong,Defa Li,Wei Jia

DOI: https://doi.org/10.6084/m9.figshare.5705347.v1

2017-01-01

Abstract:Time dependent alteration of bile acids and microbes in control and HFD groups. (XLSX 33 kb)
Butyric-lauric Acid Structural Lipid Relieves Liver Inflammation and Small Intestinal Microbial Disturbance: in Obese Male C57BL/6 Mice

Wangxin Liu,Xianliang Luo,Ying Huang,Fengqin Feng,Minjie Zhao

DOI: https://doi.org/10.1016/j.fbio.2023.102944

IF: 5.318

2023-01-01

Food Bioscience

Abstract:Butyric acid and lauric acid are short chain and medium chain fatty acids, respectively. Their anti-inflammatory and lipid metabolism regulating functions are reported, while their structural lipid functional activity still needs to be verified. In this study, obese mice induced by high-fat diet (HFD) were used to investigate the effects of butyric-lauric acid structural lipid (SBL) on inflammation and small intestinal microbes. In vivo, although SBL did not significantly reduce body weight (P > 0.05), it might have a positive effect on mouse liver health. Compared to the corresponding physical mixture (MBL), SBL treatment could better downregulate hepatic TNF-& alpha;, IL-1 & beta; and IL-6 expression and stimulate IL-10 expression. Similarly, compared with the HF group, the liver IL-1 & beta; and TNF-& alpha; levels in the LSBL treatment group decreased by 15.2% and 22.9%, respectively (P < 0.05). In addition, HSBL treatment increased the content of IL-10 in the liver of obese mice (increased by 26.8%, P < 0.05). Moreover, SBL more significantly upregulated Bifidobacterium abundance and inhibited the high-fat diet-induced increase in Faecalibaculum abundance. In all, SBL ameliorated HFD-induced liver inflammation and these improvements are closely associated with its positive effects on small intestinal microbiota. This study aimed to provide support and new perspectives for the development and functional exploration of short-and medium-chain fatty acid structural lipids.
Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice

Xiaojiao Zheng,Fengjie Huang,Aihua Zhao,Sha Lei,Yunjing Zhang,Guoxiang Xie,Tianlu Chen,Chun Qu,Cynthia Rajani,Bing Dong,Defa Li,Wei Jia

DOI: https://doi.org/10.1186/s12915-017-0462-7

2017-12-14

Abstract:Background: Intestinal bacteria are known to regulate bile acid (BA) homeostasis via intestinal biotransformation of BAs and stimulation of the expression of fibroblast growth factor 19 through intestinal nuclear farnesoid X receptor (FXR). On the other hand, BAs directly regulate the gut microbiota with their strong antimicrobial activities. It remains unclear, however, how mammalian BAs cross-talk with gut microbiome and shape microbial composition in a dynamic and interactive way. Results: We quantitatively profiled small molecule metabolites derived from host-microbial co-metabolism in mice, demonstrating that BAs were the most significant factor correlated with microbial alterations among all types of endogenous metabolites. A high-fat diet (HFD) intervention resulted in a rapid and significant increase in the intestinal BA pool within 12 h, followed by an alteration in microbial composition at 24 h, providing supporting evidence that BAs are major dietary factors regulating gut microbiota. Feeding mice with BAs along with a normal diet induced an obese phenotype and obesity-associated gut microbial composition, similar to HFD-fed mice. Inhibition of hepatic BA biosynthesis under HFD conditions attenuated the HFD-induced gut microbiome alterations. Both inhibition of BAs and direct suppression of microbiota improved obese phenotypes. Conclusions: Our study highlights a liver-BA-gut microbiome metabolic axis that drives significant modifications of BA and microbiota compositions capable of triggering metabolic disorders, suggesting new therapeutic strategies targeting BA metabolism for metabolic diseases.
High-fat-diet-induced gut microbiome changes in mice

Wenqi Tang,Libiao Pan,Jingjing Cheng,Xi Wang,Lu Zheng,Siyu Wang,Yudong Zhou,Hao Wang

DOI: https://doi.org/10.26599/sab.2022.9060012

2022-01-01

Stress and Brain

Abstract:Obesity is one of the most severe public health problems and may result in many other related diseases, such as heart disease, diabetes, and stroke. Living habits, particularly excessive caloric intake, are a vital contributor to increasing obesity incidence worldwide. Recent studies have revealed an intimate cross-talk between living habits and the gut microbiome. The gut microbiome has also been identified as a critical player in the cause of obesity. Here we used 16S rDNA amplicon sequencing to investigate changes in the gut microbiome composition of mice fed with a high-fat diet (HFD). The total number of OTUs, Chao index, and Shannon index of the gut microbiome showed an increase in the abundance of specific gut microbiome species. Alternatively, Simpson index indicated a decrease in gut microbiome diversity after HFD feeding. We also found that HFD leads to augments in Firmicutes:Bacteroidetes ratio mainly caused by increased Firmicutes. The total abundance of Bacteroidetes was not changed at the phylum level, while at the family level, both Rikenellaceae and Bacteroidaceae showed a significant increase after the HFD. Additionally, after HFD, we found an increase in the abundance of Proteobacteria related to inflammation and a significant decrease in the proportion of Verrucomicrobia. Our results show that HFD induces a broad gut microbiome change in mice.
Additional File 8 of Vital Members in the Gut Microbiotas Altered by Two Probiotic Bifidobacterium Strains Against Liver Damage in Rats

Hua Zha,Daiqiong Fang,Aimee Van Der Reis,Kevin Chang,Liya Yang,Jiao-Jiao Xie,Ding Shi,Qiaomai Xu,Lanjuan Li

DOI: https://doi.org/10.6084/m9.figshare.12441272

2020-01-01

Abstract:Additional file 8:Figure S4. Brief schematic diagram of the experimental design.
High-Fat Diet-Induced Decreased Circulating Bile Acids Contribute to Obesity Associated with Gut Microbiota in Mice

Haiying Cai,Junhui Zhang,Chang Liu,Thanh Ninh Le,Yuyun Lu,Fengqin Feng,Minjie Zhao

DOI: https://doi.org/10.3390/foods13050699

IF: 5.2

2024-02-25

Foods

Abstract:The altered circulating bile acids (BAs) modulate gut microbiota, energy metabolism and various physiological functions. BA profiles in liver, serum, ileum and feces of HFD-fed mice were analyzed with normal chow diet (NCD)-fed mice after 16-week feeding. Furthermore, gut microbiota was analyzed and its correlation analysis with BA was performed. The result showed that long-term HFD feeding significantly decreased hepatic and serum BA levels, mainly attributed to the inhibition of hepatic BA synthesis and the reduced reabsorption efficiency of BAs in enterohepatic circulation. It also significantly impaired glucose and lipid homeostasis and gut microbiota in mice. We found significantly higher bile salt hydrolase activity in ileal microbes and a higher ratio of free BAs to conjugated BA content in ileal contents in HFD groups compared with NCD group mice, which might account for the activated intestinal farnesoid X receptor signaling on liver BA synthesis inhibition and reduced ileal reabsorption. The decreased circulating BAs were associated with the dysregulation of the lipid metabolism according to the decreased TGR5 signaling in the ileum and BAT. In addition, it is astonishing to find extremely high percentages of taurocholate and 12-OH BAs in liver and serum BA profiles of both groups, which was mainly attributed to the high substrate selectivity for 12-OH BAs of the intestinal BAs transporter during the ileal reabsorption of enterohepatic circulation. This study revealed a significant effect of long-term HFD feeding on the decreased circulating BA pool in mice, which impaired lipid homeostasis and gut microbiota, and collectively resulted in metabolic disorders and obesity.
A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility

Meilin Wei,Fengjie Huang,Ling Zhao,Yunjing Zhang,Wei Yang,Shouli Wang,Mengci Li,Xiaolong Han,Kun Ge,Chun Qu,Cynthia Rajani,Guoxiang Xie,Xiaojiao Zheng,Aihua Zhao,Zhaoxiang Bian,Wei Jia

DOI: https://doi.org/10.1016/j.ebiom.2020.102766

IF: 11.205

EBioMedicine

Abstract:Background: The composition of the bile acid (BA) pool is closely associated with obesity and is modified by gut microbiota. Perturbations of gut microbiota shape the BA composition, which, in turn, may alter important BA signaling and affect host metabolism. Methods: We investigated BA composition of high BMI subjects from a human cohort study and a high fat diet (HFD) obesity prone (HF-OP) / HFD obesity resistant (HF-OR) mice model. Gut microbiota was analysed by metagenomics sequencing. GLP-1 secretion and gene regulation studies involved ELISA, qPCR, Western blot, Immunohistochemistry, and Immunofluorescence staining. Findings: We found that the proportion of non-12-OH BAs was significantly decreased in the unhealthy high BMI subjects. The HF-OR mice had an enhanced level of non-12-OH BAs. Non-12-OH BAs including ursodeoxycholate (UDCA), chenodeoxycholate (CDCA), and lithocholate (LCA) were decreased in the HF-OP mice and associated with altered gut microbiota. Clostridium scindens was decreased in HF-OP mice and had a positive correlation with UDCA and LCA. Gavage of Clostridium scindens in mice increased the levels of hepatic non-12-OH BAs, accompanied by elevated serum 7α-hydroxy-4-cholesten-3-one (C4) levels. In HF-OP mice, altered BA composition was associated with significantly downregulated expression of GLP-1 in ileum and PGC1α, UCP1 in brown adipose tissue. In addition, we identified that UDCA attenuated the high fat diet-induced obesity via enhancing levels of non-12-OH BAs. Interpretation: Our study highlights that dysregulated BA signaling mediated by gut microbiota contributes to obesity susceptibility, suggesting modulation of BAs could be a promising strategy for obesity therapy.
Unconjugated and Secondary Bile Acid Profiles in Response to Higher-Fat, Lower-Carbohydrate Diet and Associated with Related Gut Microbiota: A 6-Month Randomized Controlled-Feeding Trial

Yi Wan,Jihong Yuan,Jie Li,Hao Li,Jingjing Zhang,Jun Tang,Yan Ni,Tao Huang,Fenglei Wang,Feng Zhao,Duo Li

DOI: https://doi.org/10.1016/j.clnu.2019.02.037

IF: 7.643

2020-01-01

Clinical Nutrition

Abstract:Background & aims: Observational studies have shown that diets high in fat and low in dietary fiber, might have an unfavorable impact on bile acid (BA) profiles, which might further affect host cardiometabolic health. In the current study, we aimed to evaluate the effects of dietary fat content on BA profiles and associated gut microbiota, and their correlates with cardiometabolic risk factors. Methods: In a randomized controlled-feeding trial, healthy young adults were assigned to one of the three diets: a lower-fat diet (fat 20%, carbohydrate 66% and protein 14%), a moderate-fat diet (fat 30%, carbohydrate 56% and protein 14%) and a higher-fat diet (fat 40%, carbohydrate 46% and protein 14%) for 6 months. All the foods were provided during the entire intervention period. The BA profiles, associated gut microbiota and markers of cardiometabolic risk factors were determined before and after intervention. Results: The higher-fat diet resulted in an elevated concentration of total BAs (p < 0.001), and unconjugated BAs (p = 0.03) compared with lower-fat diet. Secondary BAs, such as deoxycholic acid (DCA), taurodeoxycholic acid (TDCA), 12ketolithocholic acid (12keto-LCA), 30-DCA and taurolithocholic acid (TLCA) (p < 0.05 after FDR correction) were significantly increased in the higher-fat diet group after the 6-month intervention. Consistently, the abundances of gut bacteria (Bacteroides, Clostridium, Bifidobacterium and Lactobacillus) which affect bile salt hydrolase gene expression were significantly increased after higher-fat consumption. The change of DCA was positively associated with the relative abundance of Bacteroides (r = 0.31, p = 0.08 after FDR correction). In addition, the changes of fecal concentrations of DCA and 12keto-LCA were positively associated with serum total cholesterol (r > 0.3, p = 0.02 and p = 0.008 after FDR correction, respectively). In line with these findings, serum fibroblast growth factor 19 (FGF19) was marginally significantly elevated in the higher-fat group after intervention (p = 0.05). Conclusions: The higher-fat diet resulted in an alteration of BAs, especially unconjugated BAs and secondary BAs, most likely through actions of gut microbiota. These alterations might confer potentially unfavorable impacts on colonic and host cardiometabolic health in healthy young adults. (C) 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Alterations of Bile Acids and Gut Microbiota in Obesity Induced by High Fat Diet in Rat Model.

Hong Lin,Yanpeng An,Huiru Tang,Yulan Wang

DOI: https://doi.org/10.1021/acs.jafc.9b00249

IF: 6.1

2019-01-01

Journal of Agricultural and Food Chemistry

Abstract:Obesity has become a worldwide health issue and has attracted much public attention. In the current study, we aim to elucidate the roles of bile acids and their associations with gut microbiota during obesity development, employing high fat diet (HFD)-induced obesity in a rat model. We collected feces and plasma, liver tissues, and segments of intestinal tissues and a developed bile acids quantification method by employing an ultraperformance liquid chromatography coupled with mass spectrometry detection (UPLC-MS) strategy. We then assessed bile acids fluxes in the biological matrixes collected. We found that, irrespective of dietary regimes, taurine-conjugated bile acids were the dominant species in the liver whereas unconjugated bile acids were in plasma. However, HFD caused slight increases in the total bile acids pool and particularly the increases in the levels of deoxycholic acid (DCA) (138.67 ± 37.225 nmol/L in control group, 242.61 ± 43.16 nmol/L in HFD group, p = 0.014) and taurodeoxycholic acid (TDCA) (2.8 ± 0.247 nmol/g in control group, 4.5 ± 0.386 nmol/g in HFD group, p = 0.0018) in plasma and liver tissues, respectively, which were consistent with the increased levels of DCA in intestinal tissues and feces. These changes are correlated to an increase in abundance of genera Blautia, Coprococcus, Intestinimonas, Lactococcus, Roseburia, and Ruminococcus. Our investigation revealed the fluxes of bile acids and their association with gut microbiota during obesity development and explicated unfavorable impact of HFD on health.
Additional File 5 of Vital Members in the Gut Microbiotas Altered by Two Probiotic Bifidobacterium Strains Against Liver Damage in Rats

Hua Zha,Daiqiong Fang,Aimee Van Der Reis,Kevin Chang,Liya Yang,Jiao-Jiao Xie,Ding Shi,Qiaomai Xu,Lanjuan Li

DOI: https://doi.org/10.6084/m9.figshare.12441257

2020-01-01

Abstract:Additional file 5:Figure S1. Co-occurrence network inference analysis determines the bacterial correlations in each of the seven groups.
Habitual Animal Fat Consumption in Shaping Gut Microbiota and Microbial Metabolites.

Yi Wan,Wenfeng Tong,Renke Zhou,Jie Li,Jihong Yuan,Fenglei Wang,Duo Li

DOI: https://doi.org/10.1039/c9fo01490j

IF: 6.3173

2019-01-01

Food & Function

Abstract:Short-term intervention studies support a link between animal-based diet and the outgrowth of microorganisms capable of triggering inflammatory bowel disease. However, whether habitual animal fat intake is associated with gut-related health remains unclear. Thus, we collected dietary information, clinical data and fecal samples from 297 healthy young subjects and characterized gut microbiota by 16S rRNA gene sequencing and microbial metabolites, including short-chain fatty acids (SCFAs) and bile acids (BAs) using a gas chromatography coupled to time-of-flight mass spectrometry (GC-TOF/MS) system and ultra performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) platform, respectively. We found that the microbial diversity of butyric acid (rho = -0.17, p = 0.004 for the Shannon index) and the concentrations of butyric acid (rho = -0.33, p < 0.001) and valeric acid (rho = -0.28, p = 0.002) were negatively associated with animal fat consumption. In line with this, the abundance of SCFAs-producing bacteria such as Blautia, Eubacterium hallii, and Megamonas were significantly lower in the high animal fat group compared with the low animal fat group (all p < 0.05). Additionally, the high animal fat group had higher concentrations of total (p = 0.06) and unconjugated (p = 0.09) BAs relative to the lower animal fat groups. The findings of our study indicate that a diet with higher animal-based fat consumption is likely to be associated with moderately unfavorable impacts on gut microbial diversity, community, and regulation of fecal SCFAs, which may influence the host cardiometabolic health in the long term among healthy Chinese adults whose diet is in a nutrition transition.
Gut microbiota-bile acids-glucagon like peptide-1 axis contributes the resistance to high fat diet-induced obesity in mice

Chunxiu Chen,Lingli Liu,Ying Zhong,Miaoran Wang,Yanbiao Ai,Yi Hou,Hong Chen,Xiaojing Lin,Yunqi Zhang,Min Ding,Ting Luo,Jibin Li,Xinyu Li,Xiaoqiu Xiao

DOI: https://doi.org/10.1016/j.jnutbio.2023.109358

IF: 6.117

2023-04-01

The Journal of Nutritional Biochemistry

Abstract:In human and rodents, some individuals may remain lean even when they are challenged with high calorie intake. Here, we used C57BL/6J mice to establish animal models of high-fat diet (HFD) induced obesity sensitive (DIO) mice and obesity resistant (DIR) mice. In DIR mice, improved metabolic profile through brown adipose tissue (BAT) activation was observed, while plasma unconjugated bile acids (BAs) were decreased together with increased intestine tauro-conjugated BAs (e.g., T-β-MCA). The composition of the gut flora also differs greatly between DIR and DOR. Using fecal microbiota transplants from DIR mice, HFD fed recipient mice exhibited a trend toward reduced adiposity and improved glucose tolerance, showing increased serum tauro-conjugated BAs levels. STC-1 cell experiments confirmed T-β-MCA could activate FXR/TGR5 pathway and induce the production of GLP-1, inhibiting genes that regulate the ceramide synthesis. Our results indicated that the DIR mice exhibited higher energy expenditure by activating BAT thermogenesis, which may be related to altered gut microbiota-bile acids-glucagon like peptide-1 axis.

biochemistry & molecular biology,nutrition & dietetics
In‐depth multiomic characterization of the effects of obesity in high‐fat diet‐fed mice

Boping Li,Juanjuan Chen,Xiaobin Ou,Xiuli Liu,Zaoxu Xu,Xuesong Xiang,Yan Yang,Qi Wang

DOI: https://doi.org/10.1002/2211-5463.13788

2024-03-15

FEBS Open Bio

Abstract:Using high‐fat diet‐fed mice, we carried out an in‐depth multiomic characterization of the effects of obesity and showed changes and associations among gut microbiota, colonic, plasma, and liver metabolites, and colonic and liver gene expression. Significantly altered gut microbiota was correlated with lipid transport genes in the colon and lipid metabolism genes in the liver. High‐fat diet (HFD)‐fed mice have been widely used in the clinical investigation of obesity. However, the long‐term effect of HFD on gut microbiota and metabolites, plasma and liver metabolomics, colonic and liver transcriptomics remain largely unknown. In this study, 6‐week‐old C57BL/6J male mice fed with HFD for 14 weeks showed increased obesity‐related indexes including alanine aminotransferase, aspartate aminotransferase, total cholesterol, total triglyceride, free fatty acids, lipopolysaccharides, IL‐6, and TNFα. Furthermore, microbial diversity and richness were also significantly decreased. In the colon, genes involved in tryptophan metabolism, PPAR signaling pathway, cholesterol metabolism, and lipid localization and transport, were upregulated. While in the liver, MAPK signaling and unsaturated fatty acid biosynthesis were upregulated. Metabolomic analyses revealed decreased levels of glycerophospholipids and fatty acyl, but increased amino acids, coenzymes and vitamins, and organic acids in the colon, suggesting high absorption of oxidized lipids, while acyl‐carnitine, lysophosphatidylcholine, lysophosphatidylethanolamine, and oxidized lipids were reduced in the liver, suggesting a more active lipid metabolism. Finally, correlation analyses revealed a positive correlation between gut microbiota and metabolites and the expression of genes associated with lipid localization, absorption, and transport in the colon, and nutrients and energy metabolism in the liver. Taken together, our results provide a comprehensive characterization of long‐term HFD‐induced obesity in mice.

biochemistry & molecular biology
Microbiome-metabolomics insights into the feces of high-fat diet mice to reveal the anti-obesity effects of yak (Bos grunniens) bone collagen hydrolysates

Zitao Guo,Bo Hu,Lingyu Zhu,Yuliang Yang,Chunyu Liu,Fan Liu,Yi Shi,Moying Li,Zhenghua Gu,Yu Xin,Dalong Yi,Huaigao Liu,Liang Zhang

DOI: https://doi.org/10.1016/j.foodres.2022.111024

IF: 8.1

2022-01-01

Food Research International

Abstract:In this study, a twelve-week intervention was conducted to investigate the anti-obesity effects of yak bone collagen hydrolysates (YBCH) on mice with a high-fat diet. The obesity-associated phenotypes of mice were detected and the feces of mice were jointly analyzed by 16S rRNA gene sequencing and untargeted metabolomics. Results indicated that supplementation with YBCH could ameliorate the obesity-associated phenotypes of mice, especially with the medium dose (MD) and high dose (HD) of YBCH. Compared with the high-fat diet control (HC) group, the ratio of Firmicutes and Bacteroidetes in the fecal microbiota of the low dose (LD), MD, and HD groups was separately decreased by 29.83 %, 70.85 %, and 75.70 %. Lachnospiraceae and Muribaculaceae were the key bacteria for the YBCH intervention, which might be attributed to their different substrate preferences. The joint analysis of the 16S rRNA gene sequencing and untargeted metabolomics suggested that the antiobesity effects of YBCH might be achieved by up-regulating the arginine and proline metabolism and downregulating the aromatic amino acids metabolism via the gut microbiota.
Distinct Gut Microbiota and Arachidonic Acid Metabolism in Obesity-Prone and Obesity-Resistant Mice with a High-Fat Diet

Huixia Zhang,Shiqi Chen,Liu Yang,Shuai Zhang,Linqian Qin,Haiyang Jiang

DOI: https://doi.org/10.3390/nu16111579

IF: 5.9

2024-05-24

Nutrients

Abstract:An imbalance of energy intake and expenditure is commonly considered as the fundamental cause of obesity. However, individual variations in susceptibility to obesity do indeed exist in both humans and animals, even among those with the same living environments and dietary intakes. To further explore the potential influencing factors of these individual variations, male C57BL/6J mice were used for the development of obesity-prone and obesity-resistant mice models and were fed high-fat diets for 16 weeks. Compared to the obesity-prone mice, the obesity-resistant group showed a lower body weight, liver weight, adipose accumulation and pro-inflammatory cytokine levels. 16S rRNA sequencing, which was conducted for fecal microbiota analysis, found that the fecal microbiome's structural composition and biodiversity had changed in the two groups. The genera Allobaculumbiota, SMB53, Desulfovibrio and Clostridium increased in the obesity-prone mice, and the genera Streptococcus, Odoribacter and Leuconostoc were enriched in the obesity-resistant mice. Using widely targeted metabolomics analysis, 166 differential metabolites were found, especially those products involved in arachidonic acid (AA) metabolism, which were significantly reduced in the obesity-resistant mice. Moreover, KEGG pathway analysis exhibited that AA metabolism was the most enriched pathway. Significantly altered bacteria and obesity-related parameters, as well as AA metabolites, exhibited strong correlations. Overall, the phenotypes of the obesity-prone and obesity-resistant mice were linked to gut microbiota and AA metabolism, providing new insight for developing an in-depth understanding of the driving force of obesity resistance and a scientific reference for the targeted prevention and treatment of obesity.

nutrition & dietetics
Gut microbiota affects obesity susceptibility in mice through gut metabolites

Yuhang Wen,Yadan Luo,Hao Qiu,Baoting Chen,Jingrong Huang,Shuya Lv,Yan Wang,Jiabi Li,Lingling Tao,Bailin Yang,Ke Li,Lvqin He,Manli He,Qian Yang,Zehui Yu,Wudian Xiao,Mingde Zhao,Xiaoxia Zou,Ruilin Lu,Congwei Gu

DOI: https://doi.org/10.3389/fmicb.2024.1343511

IF: 5.2

2024-02-22

Frontiers in Microbiology

Abstract:Introduction: It is well-known that different populations and animals, even experimental animals with the same rearing conditions, differ in their susceptibility to obesity. The disparity in gut microbiota could potentially account for the variation in susceptibility to obesity. However, the precise impact of gut microbiota on gut metabolites and its subsequent influence on susceptibility to obesity remains uncertain. Methods: In this study, we established obesity-prone (OP) and obesity-resistant (OR) mouse models by High Fat Diet (HFD). Fecal contents of cecum were examined using 16S rDNA sequencing and untargeted metabolomics. Correlation analysis and MIMOSA2 analysis were used to explore the association between gut microbiota and intestinal metabolites. Results: After a HFD, gut microbiota and gut metabolic profiles were significantly different between OP and OR mice. Gut microbiota after a HFD may lead to changes in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), a variety of branched fatty acid esters of hydroxy fatty acids (FAHFAs) and a variety of phospholipids to promote obesity. The bacteria g_Akkermansia (Greengene ID: 175696) may contribute to the difference in obesity susceptibility through the synthesis of glycerophosphoryl diester phosphodiesterase (glpQ) to promote choline production and the synthesis of valyl-tRNA synthetase (VARS) which promotes L-Valine degradation. In addition, gut microbiota may affect obesity and obesity susceptibility through histidine metabolism, linoleic acid metabolism and protein digestion and absorption pathways.

microbiology
The Role of Gut Microbiota in the Resistance to Obesity in Mice Fed a High Fat Diet

Wanxiu Cao,Yaoxian Chin,Xin Chen,Ye Mi,Changhu Xue,Yuming Wang,Qingjuan Tang

DOI: https://doi.org/10.1080/09637486.2019.1686608

2020-01-01

International Journal of Food Sciences and Nutrition

Abstract:The prevalence of diet induced obesity (DIO) is a huge threat to global health. Differences in gut microbiota may be concerned with DIO. Sixty male C57BL/6J mice were fed with high fat diet (HFD, 45% kcal from fat) for 16 weeks. Among them, body weight, body fat rate and the lipid content in plasma or liver of six mice (Lean (L) group) were obviously lower than average levels (Fatty (F) group). These results supported that some individuals were resistant to HFD induced obesity. Using 16S rRNA analysis to investigate the role of gut microbiota in this resistance, we found several alterations associated with the resistance, such as an increase of Muribaculaceae in L group. Moreover, analysis of predicted microbial function suggested that bacteria in F group could better utilise HFD compared to L group. In conclusion, gut microbiota might play a bigger role than diet in resisting obesity, and it could be a potential target for obesity treatment.
Bile acids altered by high fat feeding and oligofructose supplementation impact metabolic homeostasis

Rachel Meyer,Rannon Plett,Savanna Weninger,Hallie Wachsmuth,Frank Duca

DOI: https://doi.org/10.1152/physiol.2023.38.s1.5735205

IF: 11.8461

2023-05-01

Physiology

Abstract:The gut microbiota is recognized as a contributor to host metabolic homeostasis, as obesity and diabetes are associated with unique gut microbiome signatures. Further, strategies aimed at beneficially shifting the gut microbiome, such as prebiotic treatment, show promise in ameliorating metabolic disease; however, the mechanisms are not yet understood. A potential contribution of the gut microbiota to host metabolism is via modification of host and diet-derived metabolites. For example, bile acids, crucial to lipid digestion and absorption, are modified by gut microbes in the small intestine. Bile acids have also been identified as signaling molecules in the intestine, liver, adipose, and nervous system, playing a role in metabolic homeostasis. Despite their importance, few studies have examined the impact of bile acid signaling on mediating the metabolic benefits of prebiotics. We hypothesized that bile acid homeostasis is altered with dietary factors that shift the gut microbiome, including high fat diet (HFD) feeding and supplementation with the prebiotic fiber oligofructose (OFS), and that taurocholic acid (TCA) and glycodeoxycholic acid (GDCA) that are increased with HFD feeding and OFS supplementation, respectively, would recapitulate the metabolic effects of these diets. Therefore, we conducted an untargeted metabolomics analysis on small intestinal contents of rats fed chow, HFD, or HFD supplemented with OFS, identifying bile acid metabolism as a primary contributor to the observed between-group differences. We then quantified bile acid levels in the small intestine, portal vein, and liver of rats fed chow, HFD, or HFD supplemented with OFS, and identified several bile acids of interest that are altered with HFD or OFS supplementation, including TCA and GDCA. Because these bile acids activate the bile acid receptors, FXR and TGR5, that known to impact metabolic homeostasis, we treated HFD-fed mice with 50 mg/kg GDCA or TCA daily for 12 weeks and measured body weight, adiposity, glucose tolerance, food intake, and indirect calorimetry. We found that GDCA treatment improved glucose tolerance, decreased body weight and adiposity, and increased energy expenditure compared to controls. Further, TCA worsened glucose tolerance independent of body weight. The results of this study implicate GDCA and TCA in the beneficial and detrimental effects of OFS and HFD-feeding, respectively; however, more research is necessary to determine the mechanism underpinning the metabolic effects of GDCA and TCA treatment. This work was supported by the NIH R01DK1804. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

physiology
Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia

Hongtao Xu,Fang Fang,Kaizhang Wu,Jiangping Song,Yaqian Li,Xingyu Lu,Juncheng Liu,Liuyang Zhou,Wenqing Yu,Fei Yu,Jie Gao

DOI: https://doi.org/10.1186/s40168-023-01709-5

IF: 15.5

2023-11-27

Microbiome

Abstract:Diet-induced dyslipidemia is linked to the gut microbiota, but the causality of microbiota-host interaction affecting lipid metabolism remains controversial. Here, the humanized dyslipidemia mice model was successfully built by using fecal microbiota transplantation from dyslipidemic donors (FMT-dd) to study the causal role of gut microbiota in diet-induced dyslipidemia.

microbiology
High-fat Feeding Rather Than Obesity Drives Taxonomical and Functional Changes in the Gut Microbiota in Mice

Liang Xiao,Si Brask Sonne,Qiang Feng,Ning Chen,Zhongkui Xia,Xiaoping Li,Zhiwei Fang,Dongya Zhang,Even Fjære,Lisa Kolden Midtbø,Muriel Derrien,Floor Hugenholtz,Longqing Tang,Junhua Li,Jianfeng Zhang,Chuan Liu,Qin Hao,Ulla Birgitte Vogel,Alicja Mortensen,Michiel Kleerebezem,Tine Rask Licht,Huanming Yang,Jian Wang,Yingrui Li,Manimozhiyan Arumugam,Jun Wang,Lise Madsen,Karsten Kristiansen

DOI: https://doi.org/10.1186/s40168-017-0258-6

IF: 15.5

2017-01-01

Microbiome

Abstract:Background It is well known that the microbiota of high-fat (HF) diet-induced obese mice differs from that of lean mice, but to what extent, this difference reflects the obese state or the diet is unclear. To dissociate changes in the gut microbiota associated with high HF feeding from those associated with obesity, we took advantage of the different susceptibility of C57BL/6JBomTac (BL6) and 129S6/SvEvTac (Sv129) mice to diet-induced obesity and of their different responses to inhibition of cyclooxygenase (COX) activity, where inhibition of COX activity in BL6 mice prevents HF diet-induced obesity, but in Sv129 mice accentuates obesity. Results Using HiSeq-based whole genome sequencing, we identified taxonomic and functional differences in the gut microbiota of the two mouse strains fed regular low-fat or HF diets with or without supplementation with the COX-inhibitor, indomethacin. HF feeding rather than obesity development led to distinct changes in the gut microbiota. We observed a robust increase in alpha diversity, gene count, abundance of genera known to be butyrate producers, and abundance of genes involved in butyrate production in Sv129 mice compared to BL6 mice fed either a LF or a HF diet. Conversely, the abundance of genes involved in propionate metabolism, associated with increased energy harvest, was higher in BL6 mice than Sv129 mice. Conclusions The changes in the composition of the gut microbiota were predominantly driven by high-fat feeding rather than reflecting the obese state of the mice. Differences in the abundance of butyrate and propionate producing bacteria in the gut may at least in part contribute to the observed differences in obesity propensity in Sv129 and BL6 mice.

Additional File 10: Table S7. of Bile Acid is a Significant Host Factor Shaping the Gut Microbiome of Diet-Induced Obese Mice

Additional File 12: Table S8. of Bile Acid is a Significant Host Factor Shaping the Gut Microbiome of Diet-Induced Obese Mice

Butyric-lauric Acid Structural Lipid Relieves Liver Inflammation and Small Intestinal Microbial Disturbance: in Obese Male C57BL/6 Mice

Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice

High-fat-diet-induced gut microbiome changes in mice

Additional File 8 of Vital Members in the Gut Microbiotas Altered by Two Probiotic Bifidobacterium Strains Against Liver Damage in Rats

High-Fat Diet-Induced Decreased Circulating Bile Acids Contribute to Obesity Associated with Gut Microbiota in Mice

A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility

Unconjugated and Secondary Bile Acid Profiles in Response to Higher-Fat, Lower-Carbohydrate Diet and Associated with Related Gut Microbiota: A 6-Month Randomized Controlled-Feeding Trial

Alterations of Bile Acids and Gut Microbiota in Obesity Induced by High Fat Diet in Rat Model.

Additional File 5 of Vital Members in the Gut Microbiotas Altered by Two Probiotic Bifidobacterium Strains Against Liver Damage in Rats

Habitual Animal Fat Consumption in Shaping Gut Microbiota and Microbial Metabolites.

Gut microbiota-bile acids-glucagon like peptide-1 axis contributes the resistance to high fat diet-induced obesity in mice

In‐depth multiomic characterization of the effects of obesity in high‐fat diet‐fed mice

Microbiome-metabolomics insights into the feces of high-fat diet mice to reveal the anti-obesity effects of yak (Bos grunniens) bone collagen hydrolysates

Distinct Gut Microbiota and Arachidonic Acid Metabolism in Obesity-Prone and Obesity-Resistant Mice with a High-Fat Diet

Gut microbiota affects obesity susceptibility in mice through gut metabolites

The Role of Gut Microbiota in the Resistance to Obesity in Mice Fed a High Fat Diet

Bile acids altered by high fat feeding and oligofructose supplementation impact metabolic homeostasis

Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia

High-fat Feeding Rather Than Obesity Drives Taxonomical and Functional Changes in the Gut Microbiota in Mice